Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates

The efficacy of current chemotherapy options in advanced esophago-gastric cancer has reached a plateau. Investigate strategies should focus in the development of new agenda and on predictive markers to tailor the efficacy of drugs to specific patient or tumor characteristics.

Study Number: 

I 169210

Principal Investigator: 
ClinicalTrials.Gov ID: 

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail